Anke L. Stuurman

Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods

Cheryl Gibbons, Marie‐Josée J. Mangen, Arie H. Havelaar et al. · BMC Public Health · 2014 · 393 citations · Full text

Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom

Corinne Willame, Dominique Rosillon, Julia Zima et al. · Human Vaccines & Immunotherapeutics · 2016 · 51 citations · Full text

Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment

Anke L. Stuurman, Margarita Riera-Montes, Smaragda Lamprianou et al. · Vaccine · 2018 · 22 citations · Full text

Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project

Anke L. Stuurman, Miriam Levi, Philippe Beutels et al. · Influenza and Other Respiratory Viruses · 2022 · 13 citations · Full text

Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink

Germano Ferreira, Anke L. Stuurman, Yves Horsmans et al. · European Journal of Gastroenterology & Hepatology · 2019 · 10 citations · Full text